Integrated Wealth Concepts LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 33.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,424 shares of the exchange traded fund’s stock after selling 11,002 shares during the period. Integrated Wealth Concepts LLC’s holdings in SPDR S&P Biotech ETF were worth $2,117,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of XBI. Tidemark LLC boosted its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the last quarter. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $40,000. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $49,000.
SPDR S&P Biotech ETF Trading Up 1.9 %
NYSEARCA XBI opened at $99.14 on Friday. The company has a 50 day moving average of $98.22 and a 200-day moving average of $96.80. The company has a market cap of $7.56 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $77.50 and a 1-year high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- How to Calculate Options Profits
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 10 Safe Investments with High Returns
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.